Green Tech Co.'s Permit Would Benefit Farmers, Investors
Source: Streetwise Reports  (9/8/22)
BacTech Environmental Corp. realized much of the land for its Ecuador bioleaching plant isn't needed yet, so it is letting local workers continue to farm thousands of cocoa trees. More >

Outlook for Chile After the Weekend Rejection of the New Constitution
Source: Clive Maund  (9/8/22)
In light of this weekend's rejection of a new constitution by the Chilean government, expert Clive Maund shares his view on how he believes this will impact companies within the region. More >

Nevada Gold Play Finds Undrilled Vein in Idaho
Source: Streetwise Reports  (9/8/22)
The discovery of a gold vein can dramatically change the outlook for a gold project. So when an un-drilled gold vein is discovered outcropping at surface at a gold project with a defined resource, it certainly warrants further investigation. More >

Biopharma Co. Receives Approval From FDA Panel for ALS Drug
Source: Streetwise Reports  (9/8/22)
Amylyx Pharmaceuticals Inc.'s shares traded 51% higher after the company reported that a U.S. FDA advisory committee has voted to support approval of the firm's AMX0035 for use in treating amyotrophic lateral sclerosis. Although the committee's recommendation is not binding, it is expected that the decision will provide staunch support for approval of the firm's pending NDA for AMX0035, which has a target action date of September 29, 2022. More >

Biopharma Co. Transforming Injected Drugs Into Pills
Source: Dr. Ram Selvaraju  (9/7/22)
This Israeli firm recently attracted the attention of the US-based financial institution, H.C. Wainwright & Co., which launched analyst coverage of it. More >

Expert Says Life Science Corp.'s Technical Case Is Becoming Compelling
Source: Clive Maund  (9/7/22)
Expert Clive Maund shares his view on Awakn Life Sciences Corp. as its stock continues to strengthen. More >

Gold Co. Works To Attract Large-Tier Partner
Source: Streetwise Reports  (9/7/22)
One analyst says the work Seabridge Gold Inc. is putting in to get a permanent environmental certification could help it attract a large-tier partner in British Columbia’s Golden Triangle. More >

Why This Expert Believes Silver Investments Are at or Close to a Major Bottom
Source: Clive Maund  (9/7/22)
With the latest drop in the silver market, expert Clive Maund reviews his opinion on where he thinks silver stocks are going and why investors should play close attention to this precious metal. More >

How Long Will the Fed Keep Going?
Source: Adrian Day  (9/7/22)
Expert Adrian Day takes a look at Federal Reserve policy after Jackson Hole and what it might mean for the markets, plus updates developments at some companies on his list. More >

Oil & Gas Spinout Co Is a 'Good Buying Opportunity,' Analyst Says
Source: Bill Newman  (9/7/22)
This firm is undervalued, has a near-producing oil asset in Alberta with large resource potential and upside, and is pursuing an opportunity to expand in Thailand, noted Research Capital Corp., which initiated coverage on it. More >

Two Talks On New Cancer Drug Slated for Meeting This Week
Source: Dr. Tony Butler  (9/6/22)
The upcoming discussions pertain to a biopharma's clinical stage T-cell therapy as a treatment for solid tumors, noted a ROTH Capital Partners report. More >

Leading Producer to Advance Six Japan Gold Projects
Source: Streetwise Reports  (9/6/22)
Japan Gold Corp. shares traded 18% higher after the company reported its development partner and industry major Barrick Gold Corp. has chosen six of its gold projects in Japan to be moved forward to the second evaluation phase for advancement. More >

Drilling Fills Gaps Between Resource Pits at Gold Project
Source: Rabi Nizami   (9/4/22)
New results from this area between two deposits show greater widths and consistent grades when compared to previously reported intercepts from there, noted a National Bank of Canada report. More >

Will Pharma Co. Keep Pushing Higher After Full Data Set Released on Lung Disease Study?
Source: Streetwise Reports  (9/4/22)
One small-cap pharma co. just published more good news on a possible treatment for patients suffering from idiopathic pulmonary fibrosis, a lung disease that's usually terminal. Find out why the company has more near-term catalysts and may continue to build on an 84% gain since a private placement in mid-August. More >

Mining Co. Proves Two Gold Zones Connected
Source: Jonathan Egilo  (9/3/22)
New drill results from this Idaho project also showed there is at-surface mineralization of higher grades than the average of the current resource, noted a Desjardins report. More >

Results Point to Bulk Mining Potential at Idaho Gold Project
Source: Streetwise Reports  (9/2/22)
Drill results from Liberty Gold Corp.’s flagship Black Pine project in Idaho show that the site’s largest areas of concentrated gold are connected. More >

Denmark Co. To Buy US Biopharma Co. for $1.1 Billion
Source: Streetwise Reports  (9/2/22)
Forma Therapeutics Holdings Inc. shares traded 51% higher yesterday after the company reported it agreed to be acquired by Denmark's Novo Nordisk A/S in an all-cash deal for $20.00 per share. With the acquisition, Novo Nordisk aims to expand its global presence in the treatment of rare blood disorders and sickle cell disease. More >

B.C. Mining Explorer To Start Trading on CSE Sept. 6
Source: Streetwise Reports  (9/2/22)
The company is in the process of meeting its obligations to earn 100% of a Vancouver Island property that is prospective for precious and base minerals . . . and sasquatches. More >

Oil & Gas Producer Benefits from Surge in Natural Gas Prices
Source: Streetwise Reports  (9/2/22)
Shares of Trillion Energy International Inc. traded 14% higher to a new 52-week high after the company reported it has increased the price it receives for natural gas by 47% to US$31/Mcf. More >

'No End in Sight' Yet of Gold System at Idaho Asset
Source: Geordie Mark  (9/1/22)
New drill results highlight intra-pit continuity of mineralization and resource expansion potential, noted a Haywood Securities report. More >

Expert Rates Pharma Co. An Immediate Buy
Source: Chris Temple  (9/1/22)
Expert Chris Temple gives his view on Algernon Pharmaceuticals stock in light of its positive results for its Phase 2a study for the treatment of idiopathic pulmonary fibrosis and chronic cough. More >

Rare Earths Explorer Looks to Challenge China
Source: Streetwise Reports  (8/31/22)
This Canadian explorer is working toward a preliminary feasibility study at its Wicheeda rare earth element deposit in British Columbia. More >

Helium Co. With Acquisition in Progress Draws Attention
Source: Anish Kapadia  (8/31/22)
Hannam & Partners launched coverage on this near-term producing company set to add proven helium assets in Alberta to its large helium property portfolio in Saskatchewan. More >

Silver Miner Set to Yield 'Robust Cash Flow,' Expert Says
Source: Stephen Soock  (8/31/22)
Despite the increase in cost assumptions for the company's joint venture project in Mexico, this mining company is positioned for "robust cash flow," noted a Stifel report. More >

Uranium Co. With Big Upside as the Sector Takes Off
Source: Clive Maund  (8/31/22)
In light of the world moving away from fossil fuels, expert Clive Maund reviews Azincourt Energy Corp.'s six-month, three-year, and 12-month charts to tell you whether he believes it is a Buy. More >